Researchers have suggested the use of some acknowledged antiviral drugs like nucleoside analogs, RNA-dependent RNA polymerase (RdRp), HIV protease inhibitors, and angiotensin-converting enzyme 2 (ACE2) as promising for COVID-19 treatment (Shah et al., 2020). This evidence concerns the gene ACE2 and COVID-19.